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Hemolysis induced by long-wave ultraviolet radiation 
(UV A) and 8 different commercial tetracycline deriva-
tives was studied in a model using human red blood cells. 
Demethylchlortetracycline and doxycycline were shown 
to have pronounced hemolytic properties causing 88% 
and 85% hemolysis, respectively, at a concentration of 
50 JLg/ml and 72 Jjcm2 of UVA. Tetracycline, oxytetra-
cycline, and chlortetracycline caused maximally 18% 
hemolysis at 200 JLg/ml and lymecycline only 7 % at 100 
JLg/ml. Methacycline showed intermediate hemolytic ef-
fect of 36% at 200 llg/ml. Minocycline had no hemolytic 
effect whatsoever. These experimental data correlate 
very well with clinical reports and comparative photo-
toxicity trials in humans. Photohemolysis may thus be 
of value for predicting tetracycline phototoxicity. 
It is well documented t hat t he tetracyclines are able to induce 
li ght reactions i.n human skin and nails [1]. The incidence of 
skin photosensitivity following treatment with demethylchlor-
tetracycline (DMCT) has been reported to be especially high 
but light reactions have also been reported with doxycycline, 
methacycline, oxytetracycline, chlortetracycline, and tetracy-
cline hydrochloride [1] . To our knowledge there are no clinical 
reports about light-induced side effects with minocycline or 
lymecyc line. In the majority of cases the reaction has been of 
t he phototoxic type. 
Studies have been performed to elucidate the phototoxic 
potential of different tetracyclines. In these studies human 
volunteers have been given one of t he tetracycline derivatives 
prior to natural sunlight exposure and examined for abnormal 
sunburn reactions. Blank et a!, comparing DMCT and doxy-
cycline, t hus found 9 out of 10 and 2 out of 10 indiv idua ls, 
respectively, with abnormal reactions [2] . Frost eta!, studying 
DMCT vs methacycline, found 12 out of 13 and 1 out of 14, 
respectively, with phototoxic reactions [3]. The same investi-
gators, comparing doxycycline and mi.nocycline , noted 11 out 
of 15 and none out of 19, respectively, with abnormal reactions 
[4]. 
Different experimental models have also been used for study-
ing tetracycline phototoxicity. We have recently shown photo-
hemolysis to be an accurate method for studying DMCT pho-
totoxicity provided la rge enough doses of long-wave ultraviolet 
radiation (UVA) are applied [5]. The present study was de-
s igned to compare the photohemolytic capacity of other tetra-
cycline derivatives a nd to re late th is to clinical reports on 
phototoxic properties. 
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MATERIALS AND METHODS 
Drugs 
The 8 commercial tetracycline derivatives were provided by t he 
following companies: demethylchlortetracycline, tetracycline, chlor-
tetracycline, and minocycline by Lederle Laboratories, Pearl River, 
New York; doxycycline, oxytetracycline, and methacycline by Pfizer, 
Brussels, Belgium; and lymecycline by Farmitalia Carlo Erba, Tiiby, 
Sweden. 
Basic Experimental Design 
The photohemolysis technique described by Kahn and Fleischaker 
[6], recently modified by us [5], was used. 
Red blood cells (RBC) were obtained by venipuncture from healthy 
human volunteers not taking any drugs. RBC were drawn into ACD 
and then immediately washed in physiologic saline and centrifuged for 
10 min at 2000 rpm. This procedure was repeated 3 times, whereafter 
the RBC were stored refrigerated no longer than 40 h before use to 
avoid spontaneous hemolysis. 
The test drug was dissolved in a buffer solut ion consisting of 0.075 
M Na-Verona! (barbital) at pH 7.4 with saline to 290 mosmol/kg. Ten 
milliliters of the buffered drug solution was poured in to plastic cups 
forming a liquid layer of 7 mm. RBC 20 Ill were added to each cup, 
giving a dilution of 1:500. The cups were then irradiated with long-
wave (UV A) or medium -wave (UVB) ultraviolet radiation. A metal 
halogen lamp (Osram-Ultramed 400 W) with an emission peak at 365 
nm was used as the UVA source. A UVB filter consisting of 3-mm 
window glass was inserted between the lamp and the samples, giving 
an output in UVA of 10 m W /cm2 sat 30-cm distance as measured with 
a PUVA-meter (Waldmann AG, Schwenningen, G.F.R.). For UVB 2 
fluorescent tubes (FS 40 Westinghouse Sun Lamp, 40 W) emitting 
continuously from 280-380 nm with a peak at 313 nm were used, giving 
an output of 2.3 mW /cm2/s in the UVB region as measured with a UV-
meter (Waldmann AG) . 
Duplicate samples of drug and RBC, RBC only, as well as 1 sample 
containing drug only (the last allowing compensation for possible UV-
induced color changes of the drug) were irradiated and controls kept in 
the dark. After irradiation the samples were incubated in the dark. The 
volume of the samples was then measured to compensate for minor 
losses due to evaporation and the suspensions were transferred to test 
tubes and centrifuged for 10 min at 2000 rpm. Four milliliters of the 
supernatant was mixed with 1 ml of Drabkins' solution [K3Fe(CN)s 
200 mg, KNC 50 mg, KH2PO, 140 mg, surfactant Triton X-100 0.5 ml, 
diluted with distilled water to 1000 ml with pH 7.0- 7.4] in order to 
convert all types of hemoglobin to methemoglobin which forms the 
stable pigment cyanmethemoglobin with a maximum absorbance at 
540 nm [7]. This procedure further dilutes the hemoglobin to 1:625. 
The samples were read at 540 nm in a Beckman DB-GT spectropho-
tometer. A sample with 100% hemolysis consisted of 20 Ill of RBC in 
12.5 ml of Drabkins' solution, also giving a dilution of 1:625. 
Studies on the Photohemolytic Effect of Tetracyclines and UVA 
RBC in the presence of DMCT and doxycycline 5, 10, 25, 50, and 
100 1-'g/ml, and for the other derivatives 10, 25, 50, 100, and 200 1-'g/ml, 
were irradiated with UVA for 2 h (72 J/cm2) and dark incubated for 2 
h. For DMCT the experiment was repeated 10 times and for the other 
substances at least twice on different occasions. 
Stuaies on Irradiation with UVB 
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RBC in the presence of DMCT 50 1-'g/ml, methacycline 200 1-'g/ml, 
and oxytetracycline 200 1-'g/ml were irradiated with UVB 7, 15, and 30 
min (1, 2.1, and 4.1 J/cm2 ). These UVB doses had earlier been shown 
to have no hemolytic effect [5]. 
April1985 
Studies on Preirradiation wdh UVA 
RBC were incubated in the dark for 3 h with DMCT or doxycycline 
5, 10, 25, 50, and 100 }lg/ ml preirradiated for 2 h with UVA. 
Calculations 
All results are expressed as % hemolysis relative to the 100% he-
molysed solution using the following formula: 
(EDR - ED)V - D 
T X 100 
where EDR =optical density of exposed drug solution with RBC 
ED =optical density of exposed drug solution without RBC 
D =optical density of dark control drug solu tion 
T =optical density of total hemolysis control solution 
V = volume after irradiation 
volume before irradiation 
For statistical evaluation Student's t-test was used. 
RESULTS 
Studies on the Photohemoly tic Effect of Tetracycline and UVA 
DMCT and doxycycline showed pronounced hemolytic prop-
erties with a maximum of 88% and 85% hemolysis, respectively, 
at a concentration of 50 llg/ml (Fig 1). A dose-response curve 
leveling off above 50 llg/ml was obtained. The reproducibility 
of the results was good as shown in Fig 1. Methacycline showed 
intermediate hemolytic effect of 36% at 200 ,ug/ ml. Tetracy-
cline, oxytetracycline, and chlortetracycline caused hemolysis 
of maximally 18% at 200 ,ug/ml and lymecycline of only 7% at 
100 ,ug/ml. Minocycline had no hemolytic effect whatsoever. 
The hemolytic effect of DMCT was significantly stronger (p < 
0.001) than for the other tetracyclines, except doxycycline. 
Studies on Irradiation with UVB 
RBC in the presence of DMCT, methacycline, and oxytetra-
cycline irradiated with doses of UVB previously shown to be 
subhemolytic caused no hemolysis. 
Studies on Preirradiation with UVA 
RBC incubated with preirradiated DMCT and doxycycline 
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DISCUSSION 
The different tetracyclines thus have varying photo hemolytic 
properties. DMCT and doxycycline were strong hemolysers 
under the present conditions; methacycline intermediate; tet-
racycline, oxytetracycline, chlortetracycline, and especially ly-
mecycline were weak hemolysers; whereas minocycline showed 
no photohemolytic effect whatsoever. This corresponds fairly 
well with another experimental in vivo model measuring pho-
totoxic edema in the mouse tail. Ljunggren and Moller, testing 
the same tetracyclines, thus found DMCT, doxycycline, and to 
a lesser degree lymecycline to have phototoxic effects [8). 
RBC in the presence of DMCT, methacycline, and oxytetra-
cycline irradiated with UVB showed no hemolysis. This indi-
cates t hat the action spectrum is in the UV A as earlier reported 
in humans by Schorr and Monash (9). 
RBC incubated with preirradiated DMCT and doxycycline 
showed no hemolysis, indicating no formation of toxic photo-
products, which is the case in photohemolysis due to chlorpro-
mazine as reported by Johnson [10). 
The present photohemolytic data correspond very well with 
clinical reports on phototoxicity in humans (1]. These data are 
also in accordance with the few comparative trials between 
different tetracyclines that have been performed in humans (2-
4). It should be pointed out that the concentrations of DMCT 
and doxycycline needed to achieve total hemolysis (25-50 ,ug/ 
ml) are much higher than those found in human serum under 
therapeutic conditions (2-3 l'g/ ml) . The UV A dose given (72 
J /cm2) also is higher than under natural conditions. In another 
model using cultured human fibroblasts, however, we have 
found UVA doses as small as 1.9 J/cm2 to be phototoxic in 
combination with 10 llg/ ml of DMCT or doxycycline (unpub-
lished data) . Under natural conditions a photoaugmentative 
mechanism also may be of importance, UVB augmenting the 
phototoxic reaction caused by UV A and tetracycline, as has 
been described in mice (11]. 
Photohemolysis thus is an accurate method for studying 
tetracycline phototoxicity. In view of the good correlation with 
clinical reports and comparative trials in humans it may be of 
value as a predictive test when new tetracyclines are introduced. 









FIG 1. Dose-response curves for pho-
to hemolysis with DMCT, doxycycline, 
methacycline, tetracycline, oxytetracy-
cline, chlortetracycline, lymecycline, and 
minocycline. RBC in increasing concen-
trations of drug were irradiated for 2 h 
with UV A and dark incubated for 2 h. 
The values for DMCT are the mean of 
10 experiments, vertical bars indicating 
the SD. 
Drug concentration (fJglml) 
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